过去一年中添加的文章,按日期排序

The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients

A Botticelli, A Cirillo, G d'Amati, C Di Gioia… - … -Research and Practice, 2024 - Elsevier
11 天前 - … /metastatic head and neck squamous cell carcinoma (R/M … high levels of regulatory
T cells and immunosuppressive … cells could predict resistance to immunotherapy in patients …

CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors

J Shen, X Gong, S Tan, Y Zhang, R Xia… - Current Medicinal …, 2024 - ingentaconnect.com
12 天前 - … (MESO), head and nec squamous cell carcinoma (HNSC), … Cancer immunotherapy,
especially immune chec point … and activated memory CD4 T cells in LUAD (Fig. 7C). For …

A phase 2 study of ipatasertib in combination with pembrolizumab for first-line treatment of recurrent or metastatic squamous cell cancer of the head and neck.

JS Thomas, J Yang Bruce, Z Li, JH Lorch, T Phillips… - 2024 - ascopubs.org
42 天前 - … Regulatory T cells (Tregs) play a significant role in an immunosuppressive
tumor … in tumor immune cell infiltration, AKT signaling, and changes in peripheral blood …

… of a phase 1/2b study to evaluate pepinemab in combination with pembrolizumab for first-line treatment of patients with recurrent or metastatic head and neck cancer.

EE Evans, TL Fisher, CL Mallow, A Foster, JE Leonard… - 2024 - ascopubs.org
42 天前 - immunity within the TME and limit the efficacy of immune checkpoint inhibitors (ICIs)
in head and neck squamous cell carcinoma … cells (DC) and T cells into tertiary lymphoid …

Time restricted eating (TRE) and immunotherapy outcomes in head and neck squamous cell carcinoma (HNSCC) via modulation of microbial butyrate and tryptophan …

S Bari, M Eysha, M Alhomsi, M Hathout, K Patel, L Li… - 2024 - ascopubs.org
42 天前 - … antitumor immune response. We co-… tumor cells and the T cells under different
conditions of butyrate concentration and T cell-to-tumor cell ratio (1:5, 1:10) and evaluated T cell

[HTML][HTML] The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas

SR Chang, CH Chou, HF Tu, CJ Liu, KW Chang… - Journal of Dental …, 2024 - Elsevier
57 天前 - … Background/purpose T cells require second immune checkpoint molecules for …
HNSCC patients, thereby advancing our understanding of cancer biology and immunotherapy. …

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape

XY Zhang, JB Shi, SF Jin, RJ Wang, MY Li… - Cancer …, 2024 - Wiley Online Library
58 天前 - … (HNSCC), their objective response rate for immunotherapy is less than 20% [20]. …
HNSCC immunity by affecting T cell signaling. To further investigate the role of Kyn in T cells, …

Regulatory Tcells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer

S Suzuki, T Tsuzuki, M Saito, T Ishii… - Pathology …, 2024 - Wiley Online Library
63 天前 - … Precursor exhausted T cells: key to successful immunotherapy? Nat Rev … + T cells
in head and neck squamous cell carcinoma: implications for prognosis and immunotherapy. …

Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma

X Xu, X Pan, Z Fan, J Xia, X Ren - Cellular Signalling, 2024 - Elsevier
64 天前 - … + T cells related to glycan, amino acid and secondary metabolites, while CD4 +
T cells … The main metabolic pathways related to immunity were amino acids, secondary …

[引用][C] The Neuropilin-2 Axis Regulates Carcinogenesis and Immune Surveillance in the Oral Cavity

JY Omari - 2024